[artículo]
| Título : |
Efficacy of the novel antidepressant agomelatine on the circadian rest activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline |
| Tipo de documento: |
texto impreso |
| Autores: |
Siegfried Kasper, Autor ; Göran Hajak, Autor ; Katharina Wulff, Autor |
| Fecha de publicación: |
2022 |
| Artículo en la página: |
pp. 109-120 |
| Idioma : |
Inglés (eng) Idioma original : Inglés (eng) |
| Palabras clave: |
Antidepresivos, Ansiedad, Ritmo circadiano, Depresión, Trastorno depresivo mayor, Actividad motora, Descansar, Sertralina, Índice de gravedad de la enfermedad, Efectos del sueño. |
| Resumen: |
This study evaluates the efficacy of agomelatine, the first antidepressant to be an agonist at MT(1)/MT(2) receptors and an antagonist at 5-HT(2C) receptors, versus sertraline with regard to the amplitude of the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder (MDD). |
| Link: |
./index.php?lvl=notice_display&id=28130 |
in The Journal of Clinical Psychiatry > Año 2010 - Vol. 71 - No. 2 (Febrero) . - pp. 109-120
[artículo] Efficacy of the novel antidepressant agomelatine on the circadian rest activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline [texto impreso] / Siegfried Kasper, Autor ; Göran Hajak, Autor ; Katharina Wulff, Autor . - 2022 . - pp. 109-120. Idioma : Inglés ( eng) Idioma original : Inglés ( eng) in The Journal of Clinical Psychiatry > Año 2010 - Vol. 71 - No. 2 (Febrero) . - pp. 109-120
| Palabras clave: |
Antidepresivos, Ansiedad, Ritmo circadiano, Depresión, Trastorno depresivo mayor, Actividad motora, Descansar, Sertralina, Índice de gravedad de la enfermedad, Efectos del sueño. |
| Resumen: |
This study evaluates the efficacy of agomelatine, the first antidepressant to be an agonist at MT(1)/MT(2) receptors and an antagonist at 5-HT(2C) receptors, versus sertraline with regard to the amplitude of the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder (MDD). |
| Link: |
./index.php?lvl=notice_display&id=28130 |
|
Efficacy of the novel antidepressant agomelatine on the circadian rest activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline en The Journal of Clinical Psychiatry, Año 2010 - Vol. 71 - No. 2 (Febrero)
